IDO1/Keytruda combo trial fails in melanoma, page-16

Hi Lope

The bots were increasingly active towards end of last week and with increasing

t/o - suggesting the IDO1 results were known back then and that our drug was perceived superior.

I note all the significant sales this morning are now at 1.70.

Thanks to Davey for posting that news.

Problem is that sleuthing out the critical facts on relative efficacy is time consuming.

Also there's never sufficient detail in reports to get a true handle on those facts.

Although the VLA / Keytruda trials are collaborative between Merck & VLA you can betcha that there

are some "footnotes" re trial results that are retained by one side or other to support their bargaining position.

cheers all.